Largest companies by net assets
net assets
| Company | Net assets | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 301 | $177.01M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 302 | $174.86M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 303 | $172.96M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 304 | $172.61M | Healthcare | Medical Devices | United States | Nasdaq |
| 305 | $172.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 306 | $170.82M | Healthcare | Medical Devices | United States | Nasdaq |
| 307 | $168.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 308 | $166.41M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 309 | $165.55M | Healthcare | Biotechnology | United States | Nasdaq |
| 310 | $165.29M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 311 | $164.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 312 | $163.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 313 | $161.31M | Healthcare | Biotechnology | United States | Nasdaq |
| 314 | $158.75M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 315 | $155.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 316 | $154.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 317 | $153.44M | Healthcare | Biotechnology | United States | Nasdaq |
| 318 | $153.33M | Healthcare | Biotechnology | United States | Nasdaq |
| 319 | $148.27M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 320 | $146.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 321 | $145.61M | Healthcare | Medical Devices | United States | Nasdaq |
| 322 | $144.03M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 323 | $143.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 324 | $143.65M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 325 | $143.54M | Healthcare | Biotechnology | United States | Nasdaq |
| 326 | $142.91M | Healthcare | Biotechnology | United States | Nasdaq |
| 327 | $139.32M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 328 | $138.54M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 329 | $137.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 330 | $137.28M | Healthcare | Medical Devices | United States | Nasdaq |
| 331 | $136.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 332 | $133.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 333 | $131.11M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 334 | $130.85M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 335 | $130.39M | Healthcare | Medical Devices | United States | Nasdaq |
| 336 | $128.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 337 | $128.31M | Healthcare | Medical Devices | United States | Nasdaq |
| 338 | $128.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 339 | $127.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 340 | $127.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 341 | $126.77M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 342 | $126.13M | Healthcare | Biotechnology | United States | Nasdaq |
| 343 | $125.11M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 344 | $124.33M | Healthcare | Medical Devices | United States | NYSE |
| 345 | $122.03M | Healthcare | Medical Devices | United States | Nasdaq |
| 346 | $121.75M | Healthcare | Biotechnology | United States | Nasdaq |
| 347 | $121.14M | Healthcare | Medical Devices | United States | Nasdaq |
| 348 | $120.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 349 | $119.84M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 350 | $119.53M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 351 | $119.05M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 352 | $113.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 353 | $112.45M | Healthcare | Biotechnology | United States | Nasdaq |
| 354 | $107.38M | Healthcare | Biotechnology | United States | Nasdaq |
| 355 | $106.45M | Healthcare | Pharmaceuticals | United States | NYSE |
| 356 | $105.64M | Healthcare | Biotechnology | United States | Nasdaq |
| 357 | $105.28M | Healthcare | Biotechnology | United States | Nasdaq |
| 358 | $104.83M | Healthcare | Healthcare Providers | United States | Nasdaq |
| 359 | $103.09M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 360 | $102.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 361 | $101.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 362 | $101.75M | Healthcare | Medical Devices | United States | Nasdaq |
| 363 | $101.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 364 | $100.69M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 365 | $99.50M | Healthcare | Medical Devices | United States | Nasdaq |
| 366 | $98.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 367 | $96.34M | Healthcare | Medical Devices | United States | Nasdaq |
| 368 | $95.71M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 369 | $94.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 370 | $89.89M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 371 | $86.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 372 | $85.71M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 373 | $84.25M | Healthcare | Medical Devices | United States | Nasdaq |
| 374 | $83.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 375 | $83.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 376 | $80.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 377 | $78.63M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 378 | $76.70M | Healthcare | Biotechnology | United States | Nasdaq |
| 379 | $75.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 380 | $74.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 381 | $72.87M | Healthcare | Medical Devices | United States | NYSE |
| 382 | $72.26M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 383 | $71.77M | Healthcare | Biotechnology | United States | Nasdaq |
| 384 | $71.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 385 | $71.40M | Healthcare | Biotechnology | United States | NYSE |
| 386 | $70.02M | Healthcare | Medical Devices | United States | Nasdaq |
| 387 | $69.41M | Healthcare | Biotechnology | United States | Nasdaq |
| 388 | $69.02M | Healthcare | Biotechnology | United States | Nasdaq |
| 389 | $68.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 390 | $67.74M | Healthcare | Medical Devices | United States | Nasdaq |
| 391 | $67.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 392 | $66.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 393 | $65.98M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 394 | $64.92M | Healthcare | Medical Instruments & Supplies | United States | NYSE |
| 395 | $64.10M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 396 | $63.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 397 | $62.73M | Healthcare | Medical Instruments & Supplies | United States | Nasdaq |
| 398 | $62.60M | Healthcare | Diagnostics & Research | United States | Nasdaq |
| 399 | $61.10M | Healthcare | Biotechnology | United States | Nasdaq |
| 400 | $60.84M | Healthcare | Biotechnology | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 724 companies. Reported USD values. TTM means trailing twelve months; companies without a comparable value are excluded.